Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

544 ARTÍCULOS , VIENDO DEL 211 AL 225

A mechanistic framework linking the oral microbiome to Alzheimer's disease through neuroinflammation

Evers MJAP, Krom BP, de Jongh CA.

J Alzheimers Dis. 2026 Aug;112(3):1056-1071. doi: 10.1177/13872877261456324. Epub 2026 Jun 12.

Dynamic dual roles of gut microbial metabolites in Alzheimer's disease: Translational insights for gut-brain axis interventions

Ye X, Jing X, Li Z, Jia L, Zhong F, Luo XG.

Microbiol Res. 2026 Oct;311:128587. doi: 10.1016/j.micres.2026.128587. Epub 2026 Jun 11.

Beyond target engagement: RNA therapeutics and the neuroimmune challenge in tauopathies

Breen EA.

J Prev Alzheimers Dis. 2026 Aug;13(7):100626. doi: 10.1016/j.tjpad.2026.100626. Epub 2026 Jun 15.

Next-generation intranasal delivery nano-platforms for targeted brain therapy of Alzheimer's disease

Malaiya A, Kenwat R, Mamgain A, Paliwal SR, Sulakhiya K, Maiti S, Paliwal R.

Nanomedicine (Lond). 2026 Jun;21(12):1775-1795. doi: 10.1080/17435889.2026.2685131. Epub 2026 Jun 16.

Role of suvorexant in Alzheimer's disease: Targeting sleep, orexin signaling, and disease pathophysiology

Ahmed Abbasi A, Norouziyan F, Moradikor N.

J Alzheimers Dis. 2026 Aug;112(4):1700-1716. doi: 10.1177/13872877261461161. Epub 2026 Jun 18.

Explainable AI for MRI Alzheimer's disease classification: A comparative analysis

Persson S, Svenberg H, Rial AM, Ferreira D, Moreno R; Alzheimer’s Disease Neuroimaging Initiative.

Neuroimage. 2026 Sep;338:122043. doi: 10.1016/j.neuroimage.2026.122043. Epub 2026 Jun 18.

RNA acetylation modification ac4C: An emerging regulatory hub of RNA metabolism disruption in Alzheimer's disease

Xing L, Liu A, Li J, Jiang K, Li H.

Mol Biol Rep. 2026 Jun 19;53(1):968. doi: 10.1007/s11033-026-12148-4.

A Comprehensive Review on the Microbial Signatures and Metabolic Mechanisms Underlying the Gut-Alzheimer's Disease Axis

Amruthavarshini SN, Kumari N, Anand S.

Mol Neurobiol. 2026 Jun 19;63(1):706. doi: 10.1007/s12035-026-06015-3.

IL-4 in Alzheimer's Disease-Mechanisms and Therapeutic Potential

Liu G, Li W, Chen J, Xu S, Liu X, Wang Z, Yang Q, Xie A, Du Y.

Mol Neurobiol. 2026 Jun 20;63(1):708. doi: 10.1007/s12035-026-06003-7.

Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer's disease

Donepudi K, Eadha S, Rodarte D, Sharma B, Kumar S.

Ageing Res Rev. 2026 Aug;120:103211. doi: 10.1016/j.arr.2026.103211. Epub 2026 Jun 21.

Reprogramming Neuroinflammation: Mitochondrial Targets and Immune Checkpoint Inhibitors in Alzheimer's Disease

Kumar N, Mir PA, Bhutia GT, Chaudhary P, Kaur G, Alam Q, Pawar SD, Gupta SK.

Mol Neurobiol. 2026 Jun 22;63(1):712. doi: 10.1007/s12035-026-05983-w.

Neuroinflammation-centered pathophysiology and therapeutic strategy design in Alzheimer's disease: Cutting-edge developments

Li D, Zhang Z, Lu L, Liu J, Cai W, Hou J, Lu Y, Yu G.

Cell Signal. 2026 Oct;146:112689. doi: 10.1016/j.cellsig.2026.112689. Epub 2026 Jun 26.

From synapses to tangles: PDE inhibitors as therapeutic modulators in Alzheimer's disease

Bagri K, Damde P, Bhatia A, Deshmukh R.

Eur J Pharmacol. 2026 Jul 15;1030:179084. doi: 10.1016/j.ejphar.2026.179084. Epub 2026 Jun 23.

Battling Parkinson's and Alzheimer's: The Neuroprotective Power of Carnosic Acid

Goyal A, Verma A, Kumari A, Mishra MK.

J Biochem Mol Toxicol. 2026 Jul;40(7):e70991. doi: 10.1002/jbt.70991.

Neuroinflammation in Alzheimer's Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights

Mikołajczak K, Chmiel J, Leszek J.

Cells. 2026 Jun 19;15(12):1111. doi: 10.3390/cells15121111.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias